Our Science

For years, women with otherwise healthy eggs and embryos have failed to conceive due to unhealthy endometrial linings and a failing uterus. Lacking in any clear method for ascertaining the health of the uterus, the mainstream fertility sciences have offered no clear explanation of why women experience these issues – let alone a viable and effective solution.

Until now.

Several months following the successful breakthroughs that resulted in the successful reversal of menopause through ovarian infusions of PRP (Platelet-Rich Plasma), researchers at the Genesis Athens Clinic of Greece decided to take on a new approach to women’s fertility. Despite being called one of the top ten medical breakthroughs of 2016 by New Scientist and receiving extensive global coverage, successful live births, multiple ongoing pregnancies, and an over 75% success rate for hormone restoration, for some women, ovarian PRP just didn’t go far enough.

In early 2016, Dr. Pantos and team began experimenting with endometrial infusions of PRP, in an effort to restore the health of the endometrium, endometrial lining, and uterus prior to implantation and embryo transfer. The results were exceptional – in 7 of 7 women aged 39 – 50 with endometrial linings less than 7 mm thick, the treatments were able to successfully increase endometrial thickness to fertile levels.

Further, of 16 women total studied, approximately 6 live births and 5 additional ongoing pregnancies have been recorded.

Now, for the first time, the treatment is being offered in multiple clinical trial locations across the United States – in Chicago, New York, and California – with a goal of optimizing the rate of successful pregnancy for all women, and developing the world’s first clinical standard for tracking, monitoring, and significantly improving uterine health in women.

Comprised of an international team of professional researchers, clinicians, and organizers committed to exploring new, safe, and affordable innovations in the fertility sciences, the Inovium Trials will combine a holistic and whole-body approach to rejuvenation with leading scientific methodologies for approximately 50 women desiring fertility and pregnancy. Though the trial is open to all women, women who already have donor or personal embryos ready for implantation, and who have an identified risk of failed implantation, are preferred.